Stock listing
A2JJ99 Stock Price, News, Filings & Events — Atossa Therapeutics, Inc.
Selected listing: A2JJ99 · LSX · EUR · DE
This page tracks Atossa Therapeutics, Inc.'s A2JJ99:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JJ99:LSX. A2JJ99:LSX is the stock-level entry point for investors researching Atossa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2JJ99:LSX
- Asset type
- Stock
- Market cap
- $25.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Atossa Therapeutics, Inc. A2JJ99:LSX stock context
This page tracks Atossa Therapeutics, Inc.'s A2JJ99:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JJ99:LSX. A2JJ99:LSX is the stock-level entry point for investors researching Atossa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Atossa Therapeutics, Inc.
Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positi...
July 28, 2026
Atossa Therapeutics Announces Presentation of Mechanism-Driven (Z)-Endoxifen Data in McCune-Albright Syndrome at AACR Special Conference ...
July 21, 2026
Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds
June 12, 2026
Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds
June 11, 2026
Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase ...
May 27, 2026
Atossa Therapeutics, Inc. earnings calls
Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call
March 25, 2025 · Replay with transcript and chapters
Atossa Therapeutics, Inc. (ATOS) Q4 2023 Earnings Call
March 26, 2024 · Replay with transcript and chapters
Atossa Therapeutics, Inc. (ATOS) Q3 2023 Earnings Call
October 26, 2023 · Replay with transcript and chapters
Atossa Therapeutics, Inc. (ATOS) Q2 2023 Earnings Call
August 14, 2023 · Replay with transcript and chapters
Research Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2JJ99:LSX.
Atossa Therapeutics, Inc. company profile
View the public company page for Atossa Therapeutics, Inc. on 6ix.
Atossa Therapeutics, Inc. news
Read company news and market updates connected to Atossa Therapeutics, Inc..
Atossa Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Atossa Therapeutics, Inc..
Alternate listings
ATOS:NASDAQ
US · USD
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
ATOS:BMV
MX · MXN
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
YAG:TRADEGATE
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
YAG:GETTEX
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
ATOS:BIVA
MX · MXN
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
ATOS:BOATS
US · USD
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
A2JJ99:LS
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
A41ZVB:LSX
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
YAG:DUS
DE · USD
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
YAG:FWB
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
A41ZVB:LS
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.
YAG:MUN
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is A2JJ99:LSX.